support@custommarketinsights.com+1 737 734 2707
  1. Home
  2. Press releases
  3. India Tissue Engineering Market Size Likely to Surpass at a …
Press release · Healthcare

India Tissue Engineering Market Size Likely to Surpass at a CAGR of 6.04% By 2035

Veena JagtapSr. Research AnalystPublished Source Custom Market Insights

Key highlights

  • Secondly, increased investment in research and development, both from government initiatives and private sector players, is fueling innovation in tissue engineering technologies and applications.
  • Additionally, there's a rising demand for tissue-engineered products in various medical fields, including orthopedics, wound care, and organ regeneration, driven by an aging population and the prevalence of chronic diseases.
  • By product, the synthetic scaffold material segment held the highest market share in 2025 and is expected to keep its dominance during the forecast period 2026-2035.

India Tissue Engineering Market size was valued at USD 397 Million in 2026 and is expected to reach USD 673 Million by 2035, at a CAGR of 6.04% during the forecast period 2026 - 2035.

$397 MnMarket size, 2026
$673 MnForecast, 2035
6.04%CAGR, 2026-2035

India Tissue Engineering Market Overview

Tissue engineering is an interdisciplinary field that combines principles from engineering, biology, and medicine to develop biological substitutes that can restore, maintain, or improve tissue function or replace damaged or diseased tissues or organs.

India Tissue Engineering Market 2026–2035 (By Million)
02004006002025: 37437420252026: 39739720262027: 42142120272028: 44644620282029: 47347320292030: 50250220302031: 53253220312032: 56456420322033: 59959920332034: 63563520342035: 6736732035USD Million

Source: Custom Market Insights analysis.

In India, several notable trends are shaping the landscape of tissue engineering. Firstly, there's a growing emphasis on personalized medicine, driving the development of tissue-engineered products tailored to individual patient needs.

Secondly, increased investment in research and development, both from government initiatives and private sector players, is fueling innovation in tissue engineering technologies and applications. Additionally, there's a rising demand for tissue-engineered products in various medical fields, including orthopedics, wound care, and organ regeneration, driven by an aging population and the prevalence of chronic diseases.

Moreover, collaborations between academia, industry, and healthcare institutions are fostering interdisciplinary approaches to tissue engineering research and commercialization. Lastly, advancements in biomaterials science and bioprinting technologies are enabling more precise and complex tissue constructs, paving the way for the next generation of regenerative therapies in India.

By product, the synthetic scaffold material segment held the highest market share in 2025 and is expected to keep its dominance during the forecast period 2026-2035. Synthetic scaffold materials in tissue engineering are witnessing a trend towards enhanced biocompatibility, biodegradability, and customizable properties.

Innovations focus on incorporating bioactive molecules, controlling scaffold architecture at the nanoscale, and utilizing advanced manufacturing techniques like 3D printing, fostering precise tissue regeneration while minimizing immune response and promoting cell attachment and growth.

By application, orthopedics and musculoskeletal segment held the highest market share in 2025 and is expected to keep its dominance during the forecast period 2026-2035. One emerging trend in orthopedics and musculoskeletal medicine is the increasing adoption of minimally invasive procedures.

These techniques involve smaller incisions, leading to reduced tissue damage, faster recovery times, and fewer complications for patients. Minimally invasive approaches are being utilized across various orthopedic procedures, from joint replacements to spinal surgeries.

In West India, a notable trend is the burgeoning adoption of telemedicine and digital health solutions, driven by factors such as urbanization, technological advancements, and the need for accessible healthcare. This trend is transforming healthcare delivery, enabling remote consultations, personalized care, and health monitoring, especially in densely populated urban centers.

Organogenesis Holdings Inc. is a leading regenerative medicine company offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine.

Report Scope

Feature of the Report Details
Market Size in 2026 USD 397 Million
Projected Market Size in 2035 USD 673 Million
Market Size in 2025 USD 374 Million
CAGR Growth Rate 6.04% CAGR
Base Year 2025
Forecast Period 2026-2035
Key Segment By Product, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope India
Buying Options Request tailored purchasing options to fulfil your requirements for research.

CMI has comprehensively analyzed India Tissue Engineering market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this India Tissue Engineering industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the India Tissue Engineering Market:

  • Stempeutics Research
  • TissueTech India
  • Stryker Corporation
  • Advanced Enzyme Technologies
  • Vyome Therapeutics
  • 3M India
  • Nutech Mediworld
  • LifeCell International
  • Tissue Regenix Group
  • TTK Healthcare
  • Others

The India Tissue Engineering Market is segmented as follows:

By Product

  • Synthetic Scaffold Material
  • Biologically Derived Scaffold Material
  • Others

By Application

  • Orthopedics and Musculoskeletal
  • Neurology
  • Cardiovascular
  • Skin and Integumentary
  • Dental
  • Others

By Product Type

  • Scaffold, By Material
    • Synthetic Material
    • Biological Material
      • Collagen
      • Hydrogel
      • Stem Cells
      • Others
  • Tissue Grafts, By Type
    • Allograft
    • Autograft
    • Synthetic Grafts
    • Xenograft
  • Other Products

By End User

  • Hospitals
  • Specialty Centers and Clinics
  • Ambulatory Surgical Centers

Rate this press release

Share this press release

About the author

Veena Jagtap

Sr. Research Analyst

Research Analyst at Custom Market Insights, specializing in market research, competitive analysis, industry trends, and growth opportunities. Focused on transforming complex data into actionable insights that drive strategic decision-making and business growth.

View profile and reports

About Custom Market Insights

Custom Market Insights is a market research and advisory company. It publishes syndicated reports across 18+ industries and delivers custom research, feasibility studies and market entry strategy for companies, investors and consultancies.

Sales and media enquiriessupport@custommarketinsights.com
+1 737 734 2707

###

Free sample

Get the sample report

India Tissue Engineering Market: sample pages and table of contents by email.

Security codeCode didn’t load.

We use these details only to answer this request. Privacy policy